Literature DB >> 16178120

Exenatide.

Mayer B Davidson1, Guy Bate, Peter Kirkpatrick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16178120     DOI: 10.1038/nrd1828

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  30 in total

Review 1.  Revisiting amino acids and peptides as anti-glycation agents.

Authors:  H Chilukuri; M J Kulkarni; M Fernandes
Journal:  Medchemcomm       Date:  2018-02-12       Impact factor: 3.597

2.  Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPARγ and histone acetylation.

Authors:  Su-Jin Kim; Cuilan Nian; Christopher H S McIntosh
Journal:  J Lipid Res       Date:  2011-01-18       Impact factor: 5.922

3.  GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene.

Authors:  Su-Jin Kim; Cuilan Nian; Christopher H S McIntosh
Journal:  J Lipid Res       Date:  2010-08-07       Impact factor: 5.922

4.  Albumin-coated porous hollow poly(lactic-co-glycolic acid) microparticles bound with palmityl-acylated exendin-4 as a long-acting inhalation delivery system for the treatment of diabetes.

Authors:  Hyunuk Kim; Juho Lee; Tae Hyung Kim; Eun Seong Lee; Kyung Taek Oh; Don Haeng Lee; Eun-Seok Park; You Han Bae; Kang Choon Lee; Yu Seok Youn
Journal:  Pharm Res       Date:  2011-04-07       Impact factor: 4.200

Review 5.  The connection between GRKs and various signaling pathways involved in diabetic nephropathy.

Authors:  Feng-Ling Wang; Li-Qin Tang; Wei Wei
Journal:  Mol Biol Rep       Date:  2012-02-21       Impact factor: 2.316

Review 6.  Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

7.  The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors.

Authors:  Elizabeth G Mietlicki-Baase; Pavel I Ortinski; Laura E Rupprecht; Diana R Olivos; Amber L Alhadeff; R Christopher Pierce; Matthew R Hayes
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-10-08       Impact factor: 4.310

8.  Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling.

Authors:  Elizabeth G Mietlicki-Baase; Pavel I Ortinski; David J Reiner; Christopher G Sinon; James E McCutcheon; R Christopher Pierce; Mitchell F Roitman; Matthew R Hayes
Journal:  J Neurosci       Date:  2014-05-14       Impact factor: 6.167

9.  Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study.

Authors:  Tao Tao; Yi Zhang; Yu-Chen Zhu; Jia-Rong Fu; Yu-Ying Wang; Jie Cai; Jing-Yu Ma; Yu Xu; Yi-Ning Gao; Yun Sun; WuQiang Fan; Wei Liu
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

Review 10.  Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?

Authors:  Tito Borner; Ian C Tinsley; Robert P Doyle; Matthew R Hayes; Bart C De Jonghe
Journal:  Br J Pharmacol       Date:  2021-09-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.